FINGOLIMOD for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 351 adverse event reports in the FDA FAERS database where FINGOLIMOD was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for FINGOLIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 8,901 | 12.6% | 34 | 921 |
| Multiple sclerosis relapse | 6,728 | 9.5% | 52 | 1,787 |
| Headache | 5,993 | 8.5% | 30 | 754 |
| Dizziness | 4,317 | 6.1% | 13 | 627 |
| White blood cell count decreased | 3,597 | 5.1% | 14 | 311 |
| Lymphocyte count decreased | 3,232 | 4.6% | 31 | 499 |
| Hypoaesthesia | 3,180 | 4.5% | 14 | 684 |
| Gait disturbance | 3,007 | 4.2% | 24 | 754 |
| Fall | 2,715 | 3.8% | 19 | 727 |
| Memory impairment | 2,623 | 3.7% | 8 | 310 |
| Malaise | 2,605 | 3.7% | 22 | 543 |
| Drug ineffective | 2,571 | 3.6% | 17 | 282 |
| Nausea | 2,446 | 3.5% | 18 | 431 |
| Central nervous system lesion | 2,416 | 3.4% | 22 | 437 |
| Pain | 2,370 | 3.3% | 17 | 484 |
Other Indications for FINGOLIMOD
Multiple sclerosis (43,123)
Product used for unknown indication (16,965)
Relapsing-remitting multiple sclerosis (8,814)
Relapsing multiple sclerosis (851)
Multiple sclerosis relapse (355)
Foetal exposure during pregnancy (319)
Primary progressive multiple sclerosis (66)
Multiple sclerosis relapse prophylaxis (53)
Progressive multiple sclerosis (20)
Clinically isolated syndrome (18)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)
DALFAMPRIDINE (85)